儿童狼疮性肾炎临床特点及诊治现状

doi:10.12372/jcp.2023.23e0979

Abstract

Abstract:

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by immune dysregulation and autoantibody formation. With the progress of treatment, the survival rate of SLE patients has improved significantly. Even so, lupus nephritis (LN) is associated with high morbidity and mortality. At present, there is a lack of data on LN in children, and its diagnosis, treatment and monitoring are mainly based on guidelines for adults. Treatment is mainly based on hormones and immunosuppressants. Recently, biologics have been used to treat LN with good results and no obvious adverse reactions. This article reviews the progress of epidemiology, clinical features, pathogenesis, diagnosis and treatment of LN in children.

Key words: lupus nephritis, diagnosis, treatment, child

XIA Zhengkun, WANG Ren. Clinical characteristics and diagnosis of lupus nephritis in children[J].Journal of Clinical Pediatrics, 2023, 41(12): 881-886.

References 32

[1]	Chan EY, Yap DY, Wong WT, et al. Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis[J]. Kidney Int Rep, 2022, 8(1): 141-150.
[2]	Diaz-Frias J, Badri T. Neonatal lupus erythematosus[M]. Treasure Island (FL): StatPearls Publishing, 2023.
[3]	Parikh SV, Almaani S, Brodsky S, et al. Update on lupus nephritis: core curriculum 2020[J]. Am J Kidney Dis, 2020, 76(2): 265-281. doi: S0272-6386(19)31170-9 pmid: 32220510
[4]	Qiu S, Zhang H, Yu S, et al. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis[J]. Pediatr Nephrol, 2022, 37(2): 367-376. doi: 10.1007/s00467-021-05164-y
[5]	Shi Y, Bi D, Wang Y, et al. Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus[J]. Front Med (Lausanne), 2022, 9: 984183.
[6]	Gutiérrez-Suárez R, Ruperto N, Gastaldi R, et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1, 015 patients with juvenile-onset systemic lupus erythematosus[J]. Arthritis Rheum, 2006, 54(9): 2989-2996. doi: 10.1002/art.v54:9
[7]	Pinheiro SVB, Dias RF, Fabiano RCG, et al. Pediatric lupus nephritis[J]. J Bras Nefrol, 2019, 41(2): 252-265. doi: S0101-28002019000200252 pmid: 30465590
[8]	Weiss JE, Sison CP, Ilowite NT, et al. Flares in pediatric systemic lupus erythematosus[J]. J Rheumatol, 2007, 34(6): 1341-1344. pmid: 17477466
[9]	Aggarwal A, Phatak S, Srivastava P, et al. Outcomes in juvenile onset lupus: single center cohort from a developing country[J]. Lupus, 2018, 27(11): 1867-1875. doi: 10.1177/0961203318791046 pmid: 30071768
[10]	Yung S, Yap DY, Chan TM. A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies[J]. F1000 Res, 2020, 9: F1000 Faculty Rev-905.
[11]	Hagberg N, Rönnblom L. Interferon-α enhances the IL-12-induced STAT4 activation selectively in carriers of the STAT4 SLE risk allele rs7574865 [T][J]. Ann Rheum Dis, 2019, 78(3): 429-431. doi: 10.1136/annrheumdis-2018-213836 pmid: 30269051
[12]	Azzouz D, Omarbekova A, Heguy A, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal[J]. Ann Rheum Dis, 2019, 78(7): 947-956. doi: 10.1136/annrheumdis-2018-214856 pmid: 30782585
[13]	Peene I, Elewaut D. Changing the wolf from outside: how microbiota trigger systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(7): 867-869. doi: 10.1136/annrheumdis-2019-215221 pmid: 31076388
[14]	Kostopoulou M, Fanouriakis A, Bertsias G, et al. Annals of the rheumatic diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy[J]. Ann Rheum Dis, 2023, 82(6): 729-733. doi: 10.1136/ard-2023-223880
[15]	Frangou E, Chrysanthopoulou A, Mitsios A, et al. REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)[J]. Ann Rheum Dis, 2019, 78(2): 238-248. doi: 10.1136/annrheumdis-2018-213181 pmid: 30563869
[16]	Reid S, Alexsson A, Frodlund M, et al. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus[J]. Ann Rheum Dis, 2020, 79(3): 363-369. doi: 10.1136/annrheumdis-2019-216227 pmid: 31826855
[17]	中华医学会儿科学分会免疫学组, 中华儿科杂志编辑委员会. 中国儿童系统性红斑狼疮诊断与治疗指南[J]. 中华儿科杂志, 2021, 59(12): 1009-1024.
[18]	Fanouriakis A, Kostopoulou M, Cheema K, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis[J]. Ann Rheum Dis, 2020, 79(6): 713-723. doi: 10.1136/annrheumdis-2020-216924 pmid: 32220834
[19]	中华医学会儿科学分会肾脏学组. 狼疮性肾炎诊治循证指南(2016)[J]. 中华儿科杂志, 2018, 56(2): 88-94.
[20]	Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited[J]. Kidney Int, 2004, 65(2): 521-530. doi: 10.1111/j.1523-1755.2004.00443.x pmid: 14717922
[21]	Kaneko M, Jackson SW. Recent advances in immuno-therapies for lupus nephritis[J]. Pediatr Nephrol, 2023, 38(4): 1001-1012. doi: 10.1007/s00467-022-05670-7
[22]	Štambuk SK, Padjen I, Jukić NB, et al. Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption[J]. Clin Rheumatol, 2023, 42(6): 1723-1725. doi: 10.1007/s10067-023-06611-x
[23]	Thakur N, Rai N, Batra P. Pediatric lupus nephritis-review of literature[J]. Curr Rheumatol Rev, 2017, 13(1): 29-36. doi: 10.2174/1573397112666160404124308 pmid: 27041086
[24]	Liu Z, Zhang H, Liu Z, et al. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial[J]. Ann Intern Med, 2015, 162(1): 18-26. doi: 10.7326/M14-1030 pmid: 25383558
[25]	Rovin BH, Solomons N, Pendergraft WF 3rd, et al. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis[J]. Kidney Int, 2019, 95(1): 219-231. doi: S0085-2538(18)30628-8 pmid: 30420324
[26]	Palmer SC, Tunnicliffe DJ, Singh-Grewal D, et al. Induction and maintenance immunosuppression treatment of proliferative lupus nephritis: a network meta-analysis of randomized trials[J]. Am J Kidney Dis, 2017, 70(3): 324-336. doi: 10.1053/j.ajkd.2016.12.008
[27]	van Gelder T, Lerma E, Engelke K, et al. Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis[J]. Expert Rev Clin Pharmacol, 2022, 15(5): 515-529. doi: 10.1080/17512433.2022.2092470
[28]	中华医学会肾脏病学分会专家组. 利妥昔单抗在肾小球肾炎中应用的专家共识[J]. 中华肾脏病杂志, 2022, 38(2): 151-160. doi: 10.3760/cma.j.cn441217-20210615-00023
[29]	Yu C, Li P, Dang X, et al. Lupus nephritis: new progress in diagnosis and treatment[J]. J Autoimmun, 2022, 132: 102871. doi: 10.1016/j.jaut.2022.102871
[30]	Plüß M, Piantoni S, Tampe B, et al. Belimumab for systemic lupus erythematosus - Focus on lupus nephritis[J]. Hum Vaccin Immunother, 2022, 18(5): 2072143. doi: 10.1080/21645515.2022.2072143
[31]	Furie R, Nicholls K, Cheng TT, et al. Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study[J]. Arthritis Rheumatol, 2014, 66(2): 379-389. doi: 10.1002/art.v66.2
[32]	ACCESS Trial Group. Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study[J]. Arthritis Rheumatol, 2014, 66(11): 3096-3104. doi: 10.1002/art.v66.11

Clinical characteristics and diagnosis of lupus nephritis in children

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 32

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689.
[2]	ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697.
[3]	ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704.
[4]	WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711.
[5]	WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720.
[6]	HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726.
[7]	SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732.
[8]	CHENG Yuheng, XU Zizhao, CHEN Ying. Recent advances in the diagnosis and treatment of X-linked hypophosphatemic rickets [J]. Journal of Clinical Pediatrics, 2026, 44(8): 747-754.
[9]	Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608.
[10]	Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621.
[11]	LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627.
[12]	WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635.
[13]	GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643.
[14]	YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650.
[15]	HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488.